Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.54279 | 22 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.63873 | 28 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.66404 | 29 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.64229 | 31 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.63506 | 30 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.69241 | 27 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.74024 | 30 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.65467 | 29 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.97121 | 43 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.66951 | 30 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.64762 | 29 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.71193 | 33 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.66458 | 29 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.66125 | 29 |